https://www.selleckchem.com/pr....oducts/phorbol-12-my
Main Results The sensitivity and specificity of the TRS for low-risk patients against the moderate-risk and high-risk patients were 97% (95% CI 91-99%) and 16% (95% CI 11-23%), respectively. These results corresponded to a positive likelihood ratio of 1.15 (95% CI 1.07-1.24) and a negative likelihood ratio of 0.20 (95% CI 0.06-0.65). CONCLUSIONS In this study, the TRS showed high sensitivity, making it useful in identifying patients at low risk of QTc interval prolongation. However, the low specificity of the TRS